First-in-Class Inhibitors of Oncogenic CHD1L With Preclinical Activity Against Colorectal Cancer

Since the discovery of CHD1L in 2008 it has emerged as an oncogene implicated in the pathology and poor prognosis of a variety of cancers, including gastrointestinal cancers. However, a mechanistic understanding of CHD1L as a driver of colorectal cancer (CRC) has been limited. Until now, there have...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Mol Cancer Ther
Główni autorzy: Abbott, Joshua M., Zhou, Qiong, Esquer, Hector, Pike, Laura, Broneske, Travis P., Rinaldetti, Sébastien, Abraham, Adedoyin D., Ramirez, Dominique A., Lunghofer, Paul J., Pitts, Todd M., Regan, Daniel P., Tan, Aik Choon, Gustafson, Daniel L., Messersmith, Wells A., LaBarbera, Daniel V.
Format: Artigo
Język:Inglês
Wydane: 2020
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665848/
https://ncbi.nlm.nih.gov/pubmed/32499299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0106
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy